Editas Medicine, Inc. (EDIT) Financials

EDIT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 149.3 million 144.9 million
Dec. 31, 2025 186.5 million 159.2 million
Sept. 30, 2025 201.8 million 188.3 million
June 30, 2025 210.6 million 191.4 million

EDIT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -23.2 million 2.1 million
Dec. 31, 2025 -36.4 million 2.1 million
Sept. 30, 2025 -31.3 million 2.2 million
June 30, 2025 -50.2 million 2.7 million

EDIT Net Income

No data available :(

EDIT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 123.6 million 47.2 million 10.6 million
Dec. 31, 2025 146.6 million 53.6 million 12.1 million
Sept. 30, 2025 165.6 million - 19.7 million
June 30, 2025 178.5 million - 21.1 million

EDIT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 97.9 million
Dec. 31, 2025 88.7 million
Sept. 30, 2025 90.1 million
June 30, 2025 84.4 million

EDIT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 92000 2.8 million 10.2 million -
Dec. 31, 2025 60000 27.4 million 11.4 million -
Sept. 30, 2025 433000 19.8 million 12.3 million -
June 30, 2025 - 16.2 million 12.9 million -

EDIT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 2.8 million 483000
Dec. 31, 2025 24.7 million 805000
Sept. 30, 2025 7.5 million -
June 30, 2025 3.6 million -

EDIT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

EDIT

Price: $2.36

52 week price:
1.66
4.54

Payout Ratio Range:
-3.89%
-0.13%

Earnings Per Share: -1.14 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 2.6 million

Ebitda: -26.1 million

Market Capitalization: 276.1 million

Links: